ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
As chemists have come to better understand the correlation between catalyst design and selectivity, a theme has emerged in which researchers seek to make different products from the same reactants simply by altering the catalyst. In a new example, Frank Glorius and coworkers at the University of Münster, in Germany, switched the reactivity of enals with hydrazones in cycloaddition reactions to make 1,2-diazepines or pyrazoles, depending on the choice of N-heterocyclic carbene organocatalyst (J. Am. Chem. Soc. 2014, DOI: 10.1021/ja510737n). The team discovered that a bulkier mesityl-substituted catalyst leads to [4+3] annulation, whereas a less bulkier methoxyphenyl-substituted catalyst leads to [4+1] annulation (shown). “The electronic and steric properties of the N-heterocyclic carbene organocatalyst play a vital role in controlling the reaction pathway, allowing selective access to diverse 1,2-diazepine and pyrazole derivatives from identical substrates,” the researchers note. These compounds are important heterocycles present in a range of natural products and bioactive synthetic compounds.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter